Publicaciones del Grupo

  1. Cabañas, R., Ramírez, E. & Bellón, T. Identifying the Culprit Drug in Severe Cutaneous Adverse Reactions (SCARs). Curr Treat Options Allergy 8, 194–209 (2021). https://doi.org/10.1007/s40521-021-00291-1
  2. Bautista-Villanueva S, Galleani C, Barranco R, Bellón T, Blanco M, García-Moguel I. Acute Localized Exanthematouspustulosis Due to Alendronate. J Investig Allergol Clin Immunol. 2021 May 27:0. doi: 10.18176/jiaci.0709. Epub ahead of print. PMID: 34045177.
  3. Bellón T, Rodríguez-Martín S, Cabañas R, Ramírez E, Lerma V, González-Herrada C, González O, Sendagorta E, Fiandor A, de Abajo FJ; PIELenRed study group. Assessment of drug causality in Stevens-Johnson syndrome/toxic epidermal necrolysis: Concordance between lymphocyte transformation test and ALDEN. Allergy. 2020 Apr;75(4):956-959. doi: 10.1111/all.14062. Epub 2019 Oct 21. PMID: 31557316.
  4. González-Ramos J, Lamas C, Bellón T, Ruiz-Bravo E, RamIrez E, Lerma V, Lecumberri B. Oseltamivir-induced toxic epidermal necrolysis in a patient with Cushing’s disease. Indian J Dermatol Venereol Leprol. 2020 Sep-Oct;86(5):515-518. doi: 10.4103/ijdvl.IJDVL_53_18. PMID: 30688217.
  5. Mockenhaupt M, Wang CW, Hung SI, Sekula P, Schmidt AH, Pan RY, Chen CB, Dunant A, Gouvello SL, Schumacher M, Valeyrie-Allanore L, Bellon T, Kardaun SH, Jan YS, Chung WH, Roujeau JC; RegiSCAR group. HLA-B*57:01 confers genetic susceptibility to carbamazepine-induced SJS/TEN in Europeans. Allergy. 2019 Nov;74(11):2227-2230. doi: 10.1111/all.13821. Epub 2019 May 28. PMID: 30972788.
  6. Carr DF, Wang CW, Bellón T, Ressel L, Nwikue G, Shrivastava V, Bergfeld W, Jorgensen AL, Chung WH, Pirmohamed M. Serum and blister-fluid elevation and decreased epidermal content of high-mobility group box 1 protein in drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis. Br J Dermatol. 2019 Jul;181(1):166-174. doi: 10.1111/bjd.17610. Epub 2019 Mar 26. PMID: 30613954; PMCID: PMC6617791.
  7. Bellón T. Mechanisms of Severe Cutaneous Adverse Reactions: Recent Advances. Drug Saf. 2019 Aug;42(8):973-992. doi: 10.1007/s40264-019-00825-2
  8. Marques-Mejías MA, Cabañas R, Ramírez E, Domínguez-Ortega J, Fiandor A, Trigo E, Quirce S, Bellón T. Lymphocyte Transformation Test (LTT) in Allergy to Benznidazole: A Promising Approach. Front Pharmacol. 2019 May 21;10:469. doi: 10.3389/fphar.2019.00469. PMID: 31164819; PMCID: PMC6536588.
  9. Movsisyan M, Fiandor A, González-Muñoz M, Quirce S, Bellón T, Hakobyan A, Marques-Mejias MA, Domínguez-Ortega J, Cabañas R. The Lymphocyte Transformation Test Is Useful in the Diagnosis of Fixed Drug Eruption Induced by Etoricoxib. J Investig Allergol Clin Immunol. 2019 Aug;29(4):307-309. doi: 10.18176/jiaci.0384. PMID: 31478528.
  10. Blanca-Lopez N, Somoza-Alvarez ML, Bellon T, Amo G, Canto G, Blanca M. NSAIDs hypersensitivity: questions not resolved. Curr Opin Allergy Clin Immunol. 2018 Aug;18(4):291-301. doi: 10.1097/ACI.0000000000000454. Erratum in: Curr Opin Allergy Clin Immunol. 2019 Oct;19(5):544. PMID: 29878898.
  11. Rodríguez-Martín S, Martín-Merino E, Lerma V, Rodríguez-Miguel A, González O, González-Herrada C, Ramírez E, Bellón T, de Abajo FJ. Incidence of Stevens-Johnson syndrome/toxic epidermal necrolysis among new users of different individual drugs in a European population: a case-population study. Eur J Clin Pharmacol. 2019 Feb;75(2):237-246. doi: 10.1007/s00228-018-2569-3. Epub 2018 Oct 8. PMID: 30298362.
  12. Antolin-Amerigo D, Sánchez-González MJ, Barbarroja-Escudero J, Ayuso-Peralta L, Bellón-Heredia T, Ortega-Berruezo MA, Alvarez-Mon M, Rodríguez-Rodríguez M. Delayed Hypersensitivity Reaction to Oral Dimethyl Fumarate. J Investig Allergol Clin Immunol. 2018 Jun;28(3):201-203. doi: 10.18176/jiaci.0239. PMID: 29939143.
  13. Lerma V, Macías M, Toro R, Moscoso A, Alonso Y, Hernández O, de Abajo FJ. Care in patients with epidermal necrolysis in burn units. A nursing perspective. Burns. 2018 Dec;44(8):1962-1972. doi: 10.1016/j.burns.2018.06.010. Epub 2018 Jul 11. PMID: 30005991.
  14. Cabañas R, Calderón O, Ramírez E, Fiandor A, Caballero T, Heredia R, Herranz P, Madero R, Quirce S, Bellón T. Sensitivity and specificity of the lymphocyte transformation test in drug reaction with eosinophilia and systemic symptoms causality assessment. Clin Exp Allergy. 2018 Mar;48(3):325-333. doi: 10.1111/cea.13076. Epub 2018 Jan 19. PMID: 29265576.
  15. Monge-Ortega OP, Cabañas R, Fiandor A, Domínguez-Ortega J, González-Muñoz M, Quirce S, Lluch-Bernal M, Bellón T. Overlap Between DRESS Syndrome and Exanthema Induced by Sulfadiazine in a Patient Treated With Sulfamethoxazole: Utility of the Lymphocyte Transformation Test for Identification of the Culprit Drug. J Investig Allergol Clin Immunol. 2018 Apr;28(2):132-134. doi: 10.18176/jiaci.0220. PMID: 29661742.
  16. Rodríguez-Martín S, Martín-Merino E, Lerma V, Rodríguez-Miguel A, González O, González-Herrada C, Ramírez E, Bellón T, de Abajo FJ. Active surveillance of severe cutaneous adverse reactions: A case-population approach using a registry and a health care database. Pharmacoepidemiol Drug Saf. 2018 Sep;27(9):1042-1050. doi: 10.1002/pds.4622. Epub 2018 Jul 27. PMID: 30051945. Blanca-Lopez N, Somoza-Alvarez ML, Bellon T, Amo G, Canto G, Blanca M. NSAIDs hypersensitivity: questions not resolved. Curr Opin Allergy Clin Immunol. 2018 Aug;18(4):291-301. doi: 10.1097/ACI.0000000000000454. PMID:29878898
  17. González-Herrada C, Rodríguez-Martín S, Cachafeiro L, Lerma V, González O, Lorente JA, Rodríguez-Miguel A, González-Ramos J, Roustan G, Ramírez E, Bellón T, de Abajo FJ; PIELenRed Therapeutic Management Working Group. Cyclosporine Use in Epidermal Necrolysis Is Associated with an Important Mortality Reduction: Evidence from Three Different Approaches. J Invest Dermatol. 2017 Oct;137(10):2092-2100. doi: 10.1016/j.jid.2017.05.022. Epub 2017 Jun 17. PMID: 28634032.
  18. Bellón, Teresa & Cabañas, R. & González-Herrada, C. & Ramirez, Elena & González-Ramos, Jéssica & Lopez SAn Martin, Marta & Gonzalez-Valle, Olga & Fiandor, A. & Lerma, Victoria & Roustan, Gaston & Abajo, Francisco. (2017). Approach to Severe Cutaneous Adverse Drug Reactions. Current Treatment Options in Allergy. 4. 1-21. 10.1007/s40521-017-0127-3.
  19. Ramírez E, Medrano-Casique N, Tong HY, Bellón T, Cabañas R, Fiandor A, González-Ramos J, Herranz P, Trigo E, Muñoz M, Borobia AM, Carcas AJ, Frías J. Eosinophilic drug reactions detected by a prospective pharmacovigilance programme in a tertiary hospital. Br J Clin Pharmacol. 2017 Feb;83(2):400-415. doi: 10.1111/bcp.13096. Epub 2016 Oct 12. PMID: 27543764; PMCID: PMC5237701.
  20. Ramírez E, Bellón T, Tong HY, Borobia AM, de Abajo FJ, Lerma V, Moreno Hidalgo MA, Castañer JL, Cabañas R, Fiandor A, González-Ramos J, Herranz P, Cachafeiro L, González-Herrada C, González O, Aramburu JA, Laosa O, Hernández R, Carcas AJ, Frías J. Significant HLA class I type associations with aromatic antiepileptic drug (AED)-induced SJS/TEN are different from those found for the same AED-induced DRESS in the Spanish population. Pharmacol Res. 2017 Jan;115:168-178. doi: 10.1016/j.phrs.2016.11.027. Epub 2016 Nov 22. PMID: 27888155.
  21. Su SC, Mockenhaupt M, Wolkenstein P, Dunant A, Le Gouvello S, Chen CB, Chosidow O, Valeyrie-Allanore L, Bellon T, Sekula P, Wang CW, Schumacher M, Kardaun SH, Hung SI, Roujeau JC, Chung WH. Interleukin-15 Is Associated with Severity and Mortality in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis. J Invest Dermatol. 2017 May;137(5):1065-1073. doi: 10.1016/j.jid.2016.11.034. Epub 2016 Dec 21. PMID: 28011147.
  22. FJ Fernández Sánchez, M López San Martín, M J Barasona Villarejo, M R Cabañas Moreno, F Rodríguez Fernández. Manifestaciones clínicas por órganos y sistemas de las reacciones de hipersensibilidad inducidas por fármacos. Reacciones cutáneas graves. En:  I J Dávila, I Jáuregui, JM Olaguibel, JM Zubeldia, editors. Tratado de Alergología.2016 Ergon. 2ª Edición. Tomo IV, cap 13, pags 1415-1450. ISBN: 978-84-16270-40-8
  23. Sánchez-González MJ, Barbarroja-Escudero J, Antolín-Amérigo D, Rodríguez-Rodríguez M, Pericet-Fernández L, Vélez D, Bellón-Heredia T, Alvarez-Mon M. Flare-up reaction in the inoculation drug sites by glatiramer acetate: First case described. Allergol Int. 2016 Oct;65(4):469-471. doi: 10.1016/j.alit.2016.03.004. Epub 2016 Apr 16. PMID: 27094120.
  24. González-Ramos J, Noguera-Morel L, Tong HY, Ramírez E, Ruiz-Bravo E, Bellón T, Cabañas R, Cachafeiro L, Herranz-Pinto P. Two cases of overlap severe cutaneous adverse reactions to benznidazole treatment for asymptomatic Chagas disease in a nonendemic country. Br J Dermatol. 2016 Sep;175(3):604-7. doi: 10.1111/bjd.14451. Epub 2016 Apr 7. PMID: 26851874.
  25. Bellón T, Ramírez E, Borobia AM, Lerma V, Moreno-Hidalgo MA, Laosa O, Aramburu JA, González-Herrada C, de Abajo FJ. The HLA-B*15:02 allele in a Spanish Romani patient with carbamazepine-induced Stevens-Johnson syndrome. Pharmacogenomics. 2016 Apr;17(6):541-5. doi: 10.2217/pgs.16.10. Epub 2016 Mar 29. PMID: 27020614.
  26. Arruti N, Villarreal O, Bernedo N, Audicana MT, Velasco M, Uriel O, Martinez A, Bellón T. Positive Allergy Study (Intradermal, Patch, and Lymphocyte Transformation Tests) in a Case of Isoniazid-Induced DRESS. J Investig Allergol Clin Immunol. 2016;26(2):119-20. doi: 10.18176/jiaci.0025. PMID: 27164631.
  27. Belver MT, Michavila A, Bobolea I, Feito M, Bellón T, Quirce S. Severe delayed skin reactions related to drugs in the paediatric age group: A review of the subject by way of three cases (Stevens-Johnson syndrome, toxic epidermal necrolysis and DRESS). Allergol Immunopathol (Madr). 2016 Jan-Feb;44(1):83-95. doi: 10.1016/j.aller.2015.02.004. Epub 2015 Jun 15. PMID: 26089185.
  28. Bellón T, Lerma V, González-Valle O, González Herrada C, de Abajo FJ. Vemurafenib-induced toxic epidermal necrolysis: possible cross-reactivity with other sulfonamide compounds. Br J Dermatol. 2016 Mar;174(3):621-4. doi: 10.1111/bjd.14201. Epub 2015 Dec 30. PMID: 26412570.
  29. Martín-Merino E, de Abajo FJ, Gil M. Risk of toxic epidermal necrolysis and Stevens-Johnson syndrome associated with benzodiazepines: a population-based cohort study. Eur J Clin Pharmacol. 2015 Jun;71(6):759-766. doi: 10.1007/s00228-015-1850-y. Epub 2015 May 5. PMID: 25939709.

Comparte esta entrada:

Compartir en LinkedIn Compartir en WhatsApp Compartir en Telegram